Streetwise Articles
York Harbour Reports Bonanza-Grade Copper in Newfoundland
Source: Bob Moriarty (3/29/22)
Bob Moriarty shares his thoughts on York Harbour Metals, which has been simmering for a decade — until recently when they made a deal on a former mine.
More >
Biotech Firm's Shares Double on $6B Deal
Source: Streetwise Reports (3/29/22)
Shares of IGM Biosciences Inc. traded 97% higher after the company reported FY/21 financial results and announced it entered into a collaborative partnership with Sanofi SA to develop six separate IgM antibody agonists for three oncology and three autoimmune/inflammation targets.
More >
Green Tech Co. Gets Early Approval for Ecuador Plant
Source: Streetwise Reports (3/29/22)
This company that specializes in bioleaching technology expects its new plant to open in Ecuador in Q1 2023.
More >
Property Gives Junior More Room to Explore
Source: Streetwise Reports (3/28/22)
This exploration and development company is expanding its opportunities with the acquisition of an Ontario property with three connected, high-grade gold deposits.
More >
Shares Rise 10% After FDA Approval of Implantable Lens
Source: Streetwise Reports (3/28/22)
STAAR Surgical Co. shares traded higher after the company reported that the U.S. FDA approved its EVO Visian® Implantable Collamer® Lenses to correct myopia (nearsightedness) and myopia with astigmatism.
More >
Phenomenal Leverage to a World-Class Discovery
Source: Michael Ballanger (3/28/22)
Michael Ballanger is never shy on opinion and in this submission he reveals a high-leverage copper play in Colombia that is in the early stages of exploration. He's convinced you should take a closer look.
More >
Junior Continues to Hit Strong Oxide Gold Intercepts
Source: The Critical Investor (3/27/22)
This junior miner, after repeatedly reporting strong drill results, could be well on its way to delineating an estimated 800-1,100koz Au oxide gold resource near surface at its project in Sonora, Mexico.
More >
LNG Terminal Operator Signs 20-Year Export Contract
Source: Streetwise Reports (3/26/22)
Shares of Texas-based LNG terminal operator NextDecade Corp. traded 31% higher after the company reported it executed a binding long-term, 20-year supply agreement with Guangdong Energy Group Natural Gas Co. Ltd.
More >
Québec Junior Nails the 'Boring Details' of De-Risking
Source: Streetwise Reports (3/25/22)
Quadrupling the two million ounces of gold it inherited from a previous miner is just one way Troilus Gold is moving ahead with de-risking and building a “generational asset” in Québec, Canada.
More >
Junior Hits More Gold Near Surface At Yellowknife
Source: The Critical Investor (3/25/22)
The Critical Investor checks in with a junior explorer after it intersects visible gold and completes a CA$5.6 million raise.
More >
Australian Miner Boosts Cape Coast Lithium Resource by 42%
Source: Streetwise Reports (3/24/22)
Shares of Atlantic Lithium Ltd. rose 17% after the company reported the lithium resource at its Ewoyaa Project in Ghana has increased by 42% to 30.1Mt @ 1.26% Li2O.
More >
Digital Identity Will Continue to Evolve in 2022 and Beyond
Source: Streetwise Reports (3/23/22)
David Lucatch, CEO and president of Liquid Avatar, spoke to Streetwise Reports about what’s ahead in 2022 for the company as well as the future of digital identity.
More >
Explorer Samples Up to 27.2% Copper at B.C. Asset
Source: Streetwise Reports (3/23/22)
A junior mining explorer releases a batch of surface fieldwork data and images from its copper project in British Columbia and prepares for a drilling campaign.
More >
Biotech Co. Posts Positive Data in Ph. 1/2 Kidney Cancer Trial
Source: Streetwise Reports (3/23/22)
Shares of 4D Pharma Plc. traded 28% higher after the company reported positive interim results from its Phase 1/2 study of its MRx0518 in combination with Merck & Co.'s KEYTRUDA® (pembrolizumab) for use in treating renal cell carcinoma.
More >
Yukon Junior Boosts Copper Resource by 43%, PEA On the Way
Source: Streetwise Reports (3/22/22)
With copper flirting with $5/lb, it’s a good time to publish an expanded high-grade copper resource on a project you own outright in a mining-friendly jurisdiction with solid infrastructure and proven route to a deep-water port. It looks even better when metals recoveries from oxide and sulphide ore are higher than 85%.
Biotech Co. Gets $2M Grant for Parkinson's Treatment
Source: Streetwise Reports (3/22/22)
Shares of SQZ Biotechnologies Co. traded 17% higher after the company reported that it has been awarded a $2 million grant from the NIH to develop a new cell replacement therapy for use in treating Parkinson's disease.
More >
Co. Awaits FDA Approval of Drug, Prepares for Launch
(3/21/22)
The biopharma's executive team is managing both time and opex spending well, noted an Oppenheimer report.
More >
The Fed Mandate Has Shifted
Source: Michael Ballanger (3/21/22)
Michael Ballanger submits that steps should be taken to end central banking, and to remove the function known as "control of the currency" from its powers.
More >
Analyst Says These 3 Stocks Are All Buys
Source: Streetwise Reports (3/21/22)
Adrian Day — editor of Adrian Day's Global Analyst — discusses six companies, several of which are Buys, and looks to the SEC's latest plans for emissions control.
More >
Gold Co. Becomes Sole Operator of Colombian Gold Mine
Source: Streetwise Reports (3/21/22)
Shares of Aris Gold Corp. traded 30% higher after the company reported it entered into an agreement to become operator of the Soto Norte Gold Project in Colombia and has taken a 20% ownership interest in the operation with an option to increase its investment to 50%.
More >
Drug Co. Gets PDUFA Date for TKI
(3/20/22)
"We expect poziotinib approval in late 2022 with sales of $21.9 million this year," noted an H.C. Wainwright & Co. report.
More >
Produce Co. to Acquire Grower of Greens
(3/19/22)
The transaction will increase the acquirer's returns and lower its operating risk, noted a ROTH Capital Partners report.
More >
Pharma Co. Gains FDA Approval for Epilepsy Seizure Drug
Source: Streetwise Reports (3/19/22)
Shares of Marinus Pharmaceuticals Inc. jumped 16.4% higher near the end of trading today after the company reported that the U.S. FDA granted approval for its ZTALMY® (ganaxolone) in treating a rare type of genetic epilepsy called CDKL5 deficiency disorder.
More >
James Bay – Quebec’s Emerging Gold Mining District
Source: Streetwise Reports (3/18/22)
The James Bay territory in northern Quebec is rich in metals, especially gold. One large mine and a few smaller ones are in production and now the race is on to drill off enough ounces to determine where the next mines will be.
More >
Analyst: Green Tech Co. at Good Buy Spot
Source: Clive Maund (3/18/22)
A green tech company that has developed technology to transform hydrocarbon waste such as tires into renewable commodity products is at another very good buy spot, analyst Clive Maund says.
More >
